Bayer: Solid business development despite COVID-19 influence

Employee safety and maintaining the supply chain continue to have top priority / Group sales (WPB). Down 2.5 per cent to 10.054 billion euros / EBITDA before special items increased by 5.6 per cent to 2.883 billion euros / Crop Science with operating growth / Sales and earnings at Pharmaceuticals mainly impacted by a volume-based […]